While Medicare doesn't currently cover anti-obesity drugs, a new report from the Congressional Budget Office estimates that ...

The three major PBMs being sued by the FTC have filed motions to disqualify the Democratic commissioners who would rule on ...

Artificial intelligence has its Nobel Prize moment. On Tuesday, the Nobel Prize in Physics went to a pair of longtime AI ...

The FDA handed down a second complete response letter to Zealand Pharma for its glucagon receptor agonist in an ultra-rare ...

This year's prestigious Nobel Prize in Chemistry has been awarded to David Baker, the director of the Institute for Protein ...

If all goes according to plan, insitro could finally start testing its first drug in clinical trials in 2026, eight years ...

Clearside Biomedical reported positive results from a Phase 2b trial of its tyrosine kinase inhibitor in patients with wet ...

Purespring Therapeutics has reeled in £80 million ($105 million) to test two gene therapies in humans. The Sofinnova Partners ...

London-based startup Basecamp Research has closed a $60 million Series B round that will help expand its genomic database and ...

Concentra Biosciences, a shell company from Tang Capital, wants to buy another biotech that has found itself in a bind. Kevin ...

Thera, Richter, InnoCare and Scholar Rock: Crinetics prices $500M offering: The San Diego biotech upsized the offering by $100 million from $400 million. The biotech last month asked the FDA to ...

Pfizer has terminated development of its RSV treatment candidate sisunatovir, a viral inhibitor picked up in its up to $525 ...